Overview

Update
Acquisitions
2 Acquisitions
IPO / Stock
Went Public on May 23, 2003 / NASDAQ:ALQA
Headquarters:
New York, New York
Description:
Alliquais a biomedical company that develops, manufactures and markets its proprietary products by utilizing a technology portfolio.
Categories:
Biotechnology, Health Diagnostics, Manufacturing
Website:
http://alliqua.com
Social:

Company Details

Update

Headquartered in New York, Alliqua, Inc., (OTCBB:ALQA) is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products, utilizing its existing technology portfolio. The company currently markets its own proprietary brands of wound dressings: SilverSeal® Hydrogel, an antimicrobial dressing; and Hydress® a moist wound dressing. We intend to pursue projects in the fields of active ingredient and transdermal drug delivery, as well as advanced wound care.

Alliqua’s core transdermal delivery technology platform is designed to deliver drugs and other beneficial ingredients through the skin. Transdermal delivery has multiple advantages over conventional oral and injection delivery including: Avoidance of hepatic first pass metabolism causing less stress on the liver; Non-invasive nature; Improved patient compliance; Discontinuation of administration by removal of the system; Lower dosage; No dependence on different metabolic rates of individuals; and No interaction with the gastrointestinal system.

In addition, Alliqua’s patch technology can be utilized for the delivery of many drugs, including various proteins that have, until now, necessitated injections or intravenous infusions.

Alliqua intends to capitalize on its technology’s other intrinsic benefits in various market verticals in the healthcare industry, including: wound healing, medical diagnostics and cosmeceuticals.

Funding Rounds (7) - $40.82M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2014$20.3M / Post Ipo Equity0
Nov, 2013$13.65M / Venture0
Nov, 2013$1M / Venture0
Jul, 2013$3M / Venture0
Nov, 2012$815k / Venture0
Mar, 2012$1.05M / Venture0
Mar, 2011$1M / Venture0

Acquisitions (2)

Update
DateAcquiredAmount
Feb 3, 2015$30.4M in Cash & Stock
May 14, 2014Unknown

Current Team (11)

Update

Offices/Locations (1)

Update
  • Office

    850 THIRD AVENUE

    SUITE 1801

    New York, New York 10022

    United States

Past Team (1)

Update

Images (1)

Update

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos